{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:33:07Z","timestamp":1788395587657,"version":"build-2803163510"},"reference-count":42,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Breast reduction mammaplasty (RMP) for symptomatic macromastia or correction of asymmetry is performed in more than 100\u2009000 patients per year in the United States. The reported incidence of significant pathologic findings (SPF), that is, carcinoma and atypical hyperplasia, ranges from 0.06% to 12.8%. No standard pathology assessment for RMP exists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives.\u2014<\/jats:title>\n                    <jats:p>To propose standard sampling for microscopic evaluation in RMP specimens, to evaluate the incidence of occult carcinoma and atypical hyperplasia, and to identify clinical risk factors for SPF in patients undergoing RMP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>All RMP specimens from 2006 to 2013 at a single institution were prospectively examined. After baseline gross and microscopic evaluations, each specimen was subjected to systematic additional sampling. The incidence of SPF was tabulated, and variables such as age, specimen weight, previous history of SPF, and results of preoperative mammogram were examined. Clinical follow-up review was also subsequently undertaken.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>A total of 595 patients were evaluated. Significant pathologic findings were present in 9.8% (58 of 595) of patients. No cancer was identified in patients younger than 40 years; the rates of carcinoma were 2.4% (14 of 595) in all patients, 3.6% (14 of 392) in patients aged 40 years or older, and 4.3% (10 of 233) in patients aged 50 years or older. No carcinoma or atypical hyperplasia was identified on preoperative mammogram. Increased sampling was associated with a significantly greater frequency of SPF only in patients aged 40 years or older.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>In patients younger than 35 years, gross-only evaluation is sufficient. However, increased sampling may be necessary in patients older than 40 years.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2016-0492-oa","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T09:40:16Z","timestamp":1502358016000},"page":"1523-1528","source":"Crossref","is-referenced-by-count":25,"title":["Recommendations for Pathologic Evaluation of Reduction Mammoplasty Specimens: A Prospective Study With Systematic Tissue Sampling"],"prefix":"10.5858","volume":"141","author":[{"given":"Abiy B.","family":"Ambaye","sequence":"first","affiliation":[{"name":"From the Departments of Pathology and Laboratory Medicine (Drs Ambaye, Goodwin, and Weaver) and Surgery (Dr MacLennan), University of Vermont Medical Center, Burlington; and the Department of Medical Biostatistics, University of Vermont, Burlington (Dr Naud)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Goodwin","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology and Laboratory Medicine (Drs Ambaye, Goodwin, and Weaver) and Surgery (Dr MacLennan), University of Vermont Medical Center, Burlington; and the Department of Medical Biostatistics, University of Vermont, Burlington (Dr Naud)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"MacLennan","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology and Laboratory Medicine (Drs Ambaye, Goodwin, and Weaver) and Surgery (Dr MacLennan), University of Vermont Medical Center, Burlington; and the Department of Medical Biostatistics, University of Vermont, Burlington (Dr Naud)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Naud","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology and Laboratory Medicine (Drs Ambaye, Goodwin, and Weaver) and Surgery (Dr MacLennan), University of Vermont Medical Center, Burlington; and the Department of Medical Biostatistics, University of Vermont, Burlington (Dr Naud)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald L.","family":"Weaver","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology and Laboratory Medicine (Drs Ambaye, Goodwin, and Weaver) and Surgery (Dr MacLennan), University of Vermont Medical Center, Burlington; and the Department of Medical Biostatistics, University of Vermont, Burlington (Dr Naud)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2017,8,10]]},"reference":[{"key":"2020081216364115800_i1543-2165-141-11-1523-b01","article-title":"2015 plastic surgery statistics","journal-title":"American Society of Plastic Surgeons Web site"},{"issue":"1","key":"2020081216364115800_i1543-2165-141-11-1523-b02","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.humpath.2013.08.010","article-title":"Incidental atypical proliferative lesions in reduction mammoplasty specimens in patients with a history of breast cancer","volume":"45","author":"Li","year":"2014","journal-title":"Hum Pathol"},{"issue":"9","key":"2020081216364115800_i1543-2165-141-11-1523-b03","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.humpath.2013.02.015","article-title":"Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women's health centers","volume":"44","author":"Desouki","year":"2013","journal-title":"Hum Pathol"},{"issue":"5","key":"2020081216364115800_i1543-2165-141-11-1523-b04","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00266-012-9919-9","article-title":"Should we be analyzing breast reduction specimens?: a systematic analysis of over 1000 consecutive cases","volume":"36","author":"Hassan","year":"2012","journal-title":"Aesthetic Plast Surg"},{"issue":"2","key":"2020081216364115800_i1543-2165-141-11-1523-b05","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/PRS.0b013e3181fed5dc","article-title":"Occult carcinoma in 866 reduction mammaplasties: preserving the choice of lumpectomy","volume":"127","author":"Slezak","year":"2011","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"2020081216364115800_i1543-2165-141-11-1523-b06","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/PRS.0b013e3181b988da","article-title":"Carcinoma and atypical hyperplasia in reduction mammaplasty: increased sampling leads to increased detection: a prospective study","volume":"124","author":"Ambaye","year":"2009","journal-title":"Plastic Reconstr Surg"},{"issue":"1","key":"2020081216364115800_i1543-2165-141-11-1523-b07","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejso.2004.07.026","article-title":"Reduction mammaplasty specimens and occult breast carcinomas","volume":"31","author":"Kakagia","year":"2005","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"2020081216364115800_i1543-2165-141-11-1523-b08","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1309\/4KD652HN739XTLM3","article-title":"Pathologic findings in reduction mammaplasty specimens","volume":"120","author":"Ishag","year":"2003","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"2020081216364115800_i1543-2165-141-11-1523-b09","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF02303678","article-title":"Contra-lateral mastoplasty for breast reconstruction: a good opportunity for glandular exploration and occult carcinomas diagnosis","volume":"4","author":"Petit","year":"1997","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"2020081216364115800_i1543-2165-141-11-1523-b10","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1097\/01.PRS.0000122212.37703.6E","article-title":"Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience","volume":"113","author":"Colwell","year":"2004","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"2020081216364115800_i1543-2165-141-11-1523-b11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00006534-199802000-00014","article-title":"Breast cancer in reduction mammoplasty: case reports and a survey of plastic surgeons","volume":"101","author":"Jansen","year":"1998","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"2020081216364115800_i1543-2165-141-11-1523-b12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/jcp.2003.012427","article-title":"Does histopathological examination of breast reduction specimens affect patient management and clinical follow up?","volume":"57","author":"Cook","year":"2004","journal-title":"Clin Pathol"},{"issue":"3","key":"2020081216364115800_i1543-2165-141-11-1523-b13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00266-002-1486-z","article-title":"Histologic profiles of breast reduction specimens","volume":"26","author":"Ayhan","year":"2002","journal-title":"Aesthetic Plast Surg"},{"issue":"3","key":"2020081216364115800_i1543-2165-141-11-1523-b14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.5858\/2000-124-0378-PMPFIH","article-title":"Prophylactic mastectomy: pathologic findings in high-risk patients","volume":"124","author":"Khurana","year":"2000","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"2020081216364115800_i1543-2165-141-11-1523-b15","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1097\/00006534-199905000-00017","article-title":"A follow-up study of 105 women with breast cancer following reduction mammaplasty","volume":"103","author":"Tang","year":"1999","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"2020081216364115800_i1543-2165-141-11-1523-b16","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1097\/00006534-199905000-00016","article-title":"Breast cancer found at the time of breast reduction","volume":"103","author":"Tang","year":"1999","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"2020081216364115800_i1543-2165-141-11-1523-b17","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1097\/00006534-199810000-00093","article-title":"Incidence of breast carcinoma in patients having reduction mammaplasty","volume":"102","author":"White","year":"1998","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"2020081216364115800_i1543-2165-141-11-1523-b18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/01.PRS.0000152683.62899.50","article-title":"Pires Viana GA. Breast pathology and reduction mammaplasty","volume":"115","author":"Pitanguy","year":"2005","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"2020081216364115800_i1543-2165-141-11-1523-b19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF01570361","article-title":"Occult breast carcinoma in patients undergoing reduction mammaplasty","volume":"13","author":"Gottlieb","year":"1989","journal-title":"Aesthetic Plast Surg"},{"issue":"6","key":"2020081216364115800_i1543-2165-141-11-1523-b20","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/00006534-198906000-00020","article-title":"Carcinoma of the breast occurring in routine reduction mammaplasty","volume":"83","author":"Dinner","year":"1989","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"2020081216364115800_i1543-2165-141-11-1523-b21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00006534-197807000-00030","article-title":"Reduction mammaplasty with discovery of occult breast carcinoma in twins: case reports","volume":"62","author":"Springer","year":"1978","journal-title":"Plast Reconstr Surg"},{"issue":"8","key":"2020081216364115800_i1543-2165-141-11-1523-b22","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0344-0338(11)80427-9","article-title":"Histological findings in breast tissue specimens from reduction mammoplasties","volume":"190","author":"Karabela-Bouropoulou","year":"1994","journal-title":"Pathol Res Pract"},{"issue":"4","key":"2020081216364115800_i1543-2165-141-11-1523-b23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0748-7983(97)90885-4","article-title":"Breast cancer and reduction mammoplasty: the role of routine pre-operative mammography","volume":"23","author":"van der Torre","year":"1997","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"2020081216364115800_i1543-2165-141-11-1523-b24","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/00006534-200010000-00053","article-title":"Coincidental breast carcinoma detection in reduction mammaplasty","volume":"106","author":"Ozmen","year":"2000","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"2020081216364115800_i1543-2165-141-11-1523-b25","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1097\/00006534-199905000-00015","article-title":"A cohort study of breast cancer risk in breast reduction patients","volume":"103","author":"Brown","year":"1999","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"2020081216364115800_i1543-2165-141-11-1523-b26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1018484616598","article-title":"Cancer following breast reduction surgery in Denmark","volume":"8","author":"Boice","year":"1997","journal-title":"Cancer Causes Control"},{"issue":"7","key":"2020081216364115800_i1543-2165-141-11-1523-b27","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/bjc.1996.172","article-title":"Breast cancer incidence subsequent to surgical reduction of the female breast","volume":"73","author":"Baasch","year":"1996","journal-title":"Br J Cancer"},{"issue":"1","key":"2020081216364115800_i1543-2165-141-11-1523-b28","first-page":"37","article-title":"Detecting breast cancer after reduction mammoplasty","volume":"34","author":"Clugston","year":"1991","journal-title":"Can J Surg"},{"issue":"2","key":"2020081216364115800_i1543-2165-141-11-1523-b29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.sap.0000100894.79413.74","article-title":"Suspicious findings in reduction mammaplasty specimens: review of 182 consecutive patients","volume":"52","author":"Kukora","year":"2004","journal-title":"Ann Plast Surg"},{"issue":"11","key":"2020081216364115800_i1543-2165-141-11-1523-b30","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/000313480306901118","article-title":"Surgical management of patients with invasive carcinoma discovered at reduction mammoplasty","volume":"69","author":"Rudolph","year":"2003","journal-title":"Am Surg"},{"issue":"suppl 1","key":"2020081216364115800_i1543-2165-141-11-1523-b31","first-page":"29A","article-title":"Significant incidental pathologic findings in reduction mammoplasty cases: a five-year review","volume":"19","author":"Goodwin","year":"2006","journal-title":"Mod Pathol"},{"issue":"1","key":"2020081216364115800_i1543-2165-141-11-1523-b32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3322\/canjclin.50.1.34","article-title":"American Cancer Society guidelines for the early detection of cancer","volume":"50","author":"Smith","year":"2000","journal-title":"CA Cancer J Clin"},{"issue":"15","key":"2020081216364115800_i1543-2165-141-11-1523-b33","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1001\/jama.2015.12783","article-title":"Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society","volume":"314","author":"Oeffinger","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"2020081216364115800_i1543-2165-141-11-1523-b34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer","volume":"353","author":"Hartmann","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"2020081216364115800_i1543-2165-141-11-1523-b35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","article-title":"Risk factors for breast cancer in women with proliferative breast disease","volume":"312","author":"Dupont","year":"1985","journal-title":"N Engl J Med"},{"issue":"5","key":"2020081216364115800_i1543-2165-141-11-1523-b36","first-page":"297","article-title":"Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types","volume":"6","author":"Marshall","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"2020081216364115800_i1543-2165-141-11-1523-b37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.SAP.0000029626.42720.B1","article-title":"Management of breast carcinoma identified intraoperatively during reduction mammaplasty","volume":"50","author":"Butler","year":"2003","journal-title":"Ann Plast Surg"},{"issue":"2","key":"2020081216364115800_i1543-2165-141-11-1523-b38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1524-4741.2003.09216.x","article-title":"Breast cancer in reduction mammaplasty specimens: case reports and guidelines","volume":"9","author":"Keleher","year":"2003","journal-title":"Breast J"},{"issue":"9586","key":"2020081216364115800_i1543-2165-141-11-1523-b39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(07)61232-X","article-title":"MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study","volume":"370","author":"Kuhl","year":"2007","journal-title":"Lancet"},{"issue":"13","key":"2020081216364115800_i1543-2165-141-11-1523-b40","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa065447","article-title":"MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer","volume":"356","author":"Lehman","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"2020081216364115800_i1543-2165-141-11-1523-b41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2559.1985.tb02445.x","article-title":"Breast reductions: what to do with all the tissue specimens?","volume":"9","author":"Bondeson","year":"1985","journal-title":"Histopathology"},{"key":"2020081216364115800_i1543-2165-141-11-1523-b42","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/jnci\/djn411","article-title":"Age-related crossover in breast cancer incidence rates between black and white ethnic groups","volume":"100","author":"Anderson","year":"2008","journal-title":"J Natl Cancer Inst"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/141\/11\/1523\/1445345\/arpa_2016-0492-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/141\/11\/1523\/1445345\/arpa_2016-0492-oa.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:35:56Z","timestamp":1764790556000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/141\/11\/article-p1523.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,10]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,8,10]]},"published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2016-0492-oa","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,10]]}}}